Home

Garancia Lil Melodráma interferon kappa beta kombájn Közönségesség ágazat

GeneCopoeia: IFN alpha signaling pathway
GeneCopoeia: IFN alpha signaling pathway

IFN-κ suppresses the replication of influenza A viruses through the  IFNAR-MAPK-Fos-CHD6 axis | Science Signaling
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis | Science Signaling

Interferon pathway in SLE: one key to unlocking the mystery of the disease  | Lupus Science & Medicine
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine

Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN)  signaling pathway | SpringerLink
Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway | SpringerLink

Early and delayed events in interferon signaling. The recognition of... |  Download Scientific Diagram
Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram

IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and  Therapeutic Potential of the Interferon Pathway in Systemic Lupus  Erythematosus and Other Autoimmune Diseases
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases

Interferons: role in cancer therapy | Immunotherapy
Interferons: role in cancer therapy | Immunotherapy

Human Type I IFN Neutralizing Antibody Mixture | PBL Assay Science
Human Type I IFN Neutralizing Antibody Mixture | PBL Assay Science

Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and  Heterogeneity across Diseases | PLOS ONE
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases | PLOS ONE

An Atomic Model of the Interferon-β Enhanceosome: Cell
An Atomic Model of the Interferon-β Enhanceosome: Cell

How cancer cells make and respond to interferon-I: Trends in Cancer
How cancer cells make and respond to interferon-I: Trends in Cancer

Decoding type I and III interferon signalling during viral infection |  Nature Microbiology
Decoding type I and III interferon signalling during viral infection | Nature Microbiology

Interferon target-gene expression and epigenomic signatures in health and  disease | Nature Immunology
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology

Frontiers | Evasion of interferon-mediated immune response by arteriviruses
Frontiers | Evasion of interferon-mediated immune response by arteriviruses

Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... |  Download Scientific Diagram
Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... | Download Scientific Diagram

Type I interferon induction and signaling during SARS-CoV-2 infection  (WP4868) - Homo sapiens | WikiPathways
Type I interferon induction and signaling during SARS-CoV-2 infection (WP4868) - Homo sapiens | WikiPathways

Interferon pathway in SLE: one key to unlocking the mystery of the disease  | Lupus Science & Medicine
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine

-Role of IFN secretion during HIV-1 infection. The presence of HIV RNA... |  Download Scientific Diagram
-Role of IFN secretion during HIV-1 infection. The presence of HIV RNA... | Download Scientific Diagram

IFN-κ suppresses the replication of influenza A viruses through the  IFNAR-MAPK-Fos-CHD6 axis | Science Signaling
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis | Science Signaling

Anti-Human IFN-Beta, Clone MMHB-1 (MAb) | PBL Assay Science
Anti-Human IFN-Beta, Clone MMHB-1 (MAb) | PBL Assay Science

Frontiers | The Role of Interferons in Inflammation and Inflammasome  Activation
Frontiers | The Role of Interferons in Inflammation and Inflammasome Activation

An open-label, randomized trial of the combination of IFN-κ plus TFF2 with  standard care in the treatment of patients with moderate COVID-19 -  eClinicalMedicine
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine

Interferons Research Area: R&D Systems
Interferons Research Area: R&D Systems

Interferons Research Area: R&D Systems
Interferons Research Area: R&D Systems